scholarly journals Evaluation of psychotropic medications use among elderly with psychiatric disorders in Saudi Arabia

2021 ◽  
Author(s):  
Abdulkarim M. Meraya ◽  
Otilia J F Banji ◽  
Moteb A Khobrani ◽  
Abdulaziz Alhossan
Keyword(s):  
Saudi Arabia ◽  
Psychiatric Disorders ◽  
Psychotropic Medications

Sleep-Related Movement Disorders

2020 ◽  
pp. 193-214
Author(s):  
Ravi Gupta
Keyword(s):  
Movement Disorder ◽  
Psychiatric Disorders ◽  
Iron Metabolism ◽  
Restless Legs Syndrome ◽  
Movement Disorders ◽  
Genetic Factors ◽  
Psychotropic Medications ◽  
Predisposing Factors ◽  
Treatable Condition

Sleep-related movement disorders include disorders that manifest as simple and mostly stereotyped movements occurring at sleep–wake interface or during sleep. Restless legs syndrome (RLS), the most common sleep-related movement disorder. RLS is a treatable condition that psychiatrists must be familiar with due to its common comorbidity with a broad range of psychiatric disorders. In addition, commonly used psychotropic medications are known to induce or worsen RLS symptoms in predisposed individuals, and these symptoms may be mistaken for akathisia or sleep-initiation insomnia and lead to mismanagement. This chapter discusses, among other RLS-related topics, the diagnosis, epidemiology, predisposing factors, genetic factors, and the role of iron metabolism.

scholarly journals Prevalence of psychiatric disorders in older patients attending an Arab tertiary facility

2012 ◽  
Vol 25 (3) ◽  
pp. 507-508
Author(s):  
Mostafa Amr ◽  
Tarek Tawfik Amin ◽  
Dahoud Al-Rhaddad ◽  
Khalid Sallam
Keyword(s):  
Saudi Arabia ◽  
Psychiatric Disorders ◽  
Developing Country ◽  
Health Problem ◽  
Older Patients ◽  
Population Aging ◽  
Psychiatric Profession

The phenomenon of population aging which was defined as an increase in the median age of the population is already a major social and health problem in a developing country such as Saudi Arabia and represents a challenge to the psychiatric profession (Hafez et al., 2000).

Effects of Psychiatric Disorders and Psychotropic Medications on Prolactin and Bone Metabolism

2004 ◽  
Vol 65 (12) ◽  
pp. 1607-1618 ◽  
Author(s):  
Madhusmita Misra ◽  
George I. Papakostas ◽  
Anne Klibanski
Keyword(s):  
Psychiatric Disorders ◽  
Bone Metabolism ◽  
Psychotropic Medications

Psychotropic Medications and Sleep

2020 ◽  
pp. 482-496
Author(s):  
William C. Jangro ◽  
Daniel A. Neff
Keyword(s):  
Psychiatric Disorders ◽  
Psychotropic Medications ◽  
Mood Stabilizers ◽  
Sleep Homeostasis ◽  
Psychiatric Population ◽  
Pharmacologic Agents

Psychiatric disorders, apart from impairing functioning during waking hours, also exert profound effects on sleep. The interventions used in treating these disorders can exert equally strong influences on sleep homeostasis. Pharmacologic agents that treat psychiatric disorders give rise to a broad range of effects on sleep, both beneficial and deleterious. This chapter reviews the available data on how sleep is affected by medications commonly used for the treatment of psychiatric disorders. While the focus will be on antidepressants, antiepileptic mood stabilizers, and antipsychotics, as these are the best studied medication classes in the psychiatric population, hypnotics and stimulants are also addressed. The authors focus, where available, on studies conducted in psychiatric populations.

Sign in / Sign up

Export Citation Format

Share Document